Yuxuan Zhu
Wenzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
UCHL1 alleviates nucleus pulposus cell senescence by promoting chaperone-mediated autophagy antagonizing autophagy-dependent ferroptosis through deubiquitination of HSPA8.
Journal: Autophagy
Published: September 03, 2025
A CREB5-NR4A1 checkpoint protects against disc degeneration by controlling ferroptosis.
Journal: Osteoarthritis and cartilage
Published: August 08, 2025
PTPN22 as a therapeutic target in intervertebral disc degeneration: Modulating mitophagy and pyroptosis through the PI3K/AKT/mTOR axis.
Journal: Journal of advanced research
Published: January 25, 2025
Macelignan Improves Functional Recovery After Spinal Cord Injury by Augmenting Autophagy via the AKT-mTOR-TFEB Signaling Pathway.
Journal: Phytotherapy research : PTR
Published: November 05, 2024
Screening of orthopedic medicines identifies raloxifene hydrochloride as a novel ferroptosis inhibitor for spinal cord injury therapy.
Journal: International immunopharmacology
Published: July 20, 2024
Activation of the Nrf2 Signaling Pathway by Tetrahydroberberine Suppresses Ferroptosis and Enhances Functional Recovery Following Spinal Cord Injury.
Journal: Molecular neurobiology
Published: July 04, 2024
Screen of FDA-approved drug library identifies vitamin K as anti-ferroptotic drug for osteoarthritis therapy through Gas6.
Journal: Journal of pharmaceutical analysis
Published: June 13, 2024
Screening of NSAIDs library identifies Tinoridine as a novel ferroptosis inhibitor for potential intervertebral disc degeneration therapy.
Journal: Free radical biology & medicine
Published: April 28, 2024
Assembled nanomedicines as efficient and safe therapeutics for articular inflammation.
Journal: International journal of pharmaceutics
Published: June 19, 2012
Showing 1-10 of 10
Last Updated: 09/26/2026